#FYI #USA #MicrobeTV #ThisWeekInVirology #DanielGriffin #VincentRacaniello #MASA #MakeAmericaSaneAgain #infectiousdiseases #vaccinate #vaccines #rabies #CDC #Ecoli #rawMilk #rawCheese #EBV #mononucleosis #MS #measles #influenza #flu #influenzaA #influenzaB #RSV #covid19 #covid #sarscov2 #LongCovid

#TWIV 1312 clinical update 09.Apr.2026

https://www.youtube.com/watch?v=zM99lfjTV-A

We’re in year 7 of COVID, and a lot has changed. We now understand far more about its long-term impact on the body and how infections can build over time. If you’ve been rethinking your approach to protection, you’re not alone, and it’s not too late to start again.

Read more and explore practical, science-based guidance here: https://whn.global/youre-not-alone-restarting-protection-in-2026/

#COVID19 #COVID #SARSCOV2 #LongCOVID #CovidIsNotOver #COVIDAwareness #LongCOVIDAwareness

Great news from Australia

$23 million for research into Post-Acute Sequelae of COVID-19

https://www.health.gov.au/news/mrff-23-million-for-research-into-post-acute-sequelae-of-covid-19

Includes:
"compare the underlying causes of PASC with illnesses that happen after a viral infection, ME/CFS, POTS & #fibromyalgia . These will be small-scale projects"

Hashtags:
@longcovid
#LongCovid #PASC #PwLC #postcovid #postcovid19 #PostCovidSyndrome #COVIDBrain #NeuroPASC
#Coronavirus
#COVID19 #COVID #COVID_19 #COVIDー19 #SARSCoV2 #auscovid19
#MEcfs @mecfs #POTS @pots

Here's the latest variant picture for Canada, to late March.

XFG.* "Stratus" remained dominant, rebounding to 55% frequency.

NB.1.8.1 "Nimbus" fell to 35%.

#COVID19 #SARSCoV2 #Canada #XFG #Stratus #NB_1_8_1 #Nimbus
🧵

Here's the latest variant picture for the United States, to late March.

The XFG.* "Stratus" variant remained dominant, but fell to 62%.

BA.3.2.* "Cicada" has debuted in the top 7 lineages, growing strongly to 12%.

#COVID19 #SARSCoV2 #USA
🧵

Here's the latest variant picture for Australia, to late March.

Several variants are churning around in a confused picture, without any one being clearly dominant.

NB.1.8.1.* "Nimbus" rebounded to 40%.

BA.3.2.* "Cicada" rebounded to 33%.

JN.1.* + DeFLuQE’s fell to 21%.

XFG.* "Stratus" fell steeply to 10%.

#COVID19 #SARSCoV2 #Australia
🧵

"Skin as a potential entry point for SARS-COV-2"

Study finds inflamed skin may increase SARS-CoV-2 entry. Cytokines raise ACE2/TMPRSS2 levels, boosting viral entry—suggesting skin could be an overlooked infection route.

#COVID19 #SARSCOV2

Source: https://www.biorxiv.org/content/10.64898/2026.04.07.717019v1

PDF: https://www.biorxiv.org/content/10.64898/2026.04.07.717019v1.full.pdf